Elena Oldani

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Renato Bassan, Orietta Spinelli, Elena Oldani et al. · Blood · 2009 · 429 citations · Full text

Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00

Renato Bassan, Giuseppe Rossi, Enrico Maria Pogliani et al. · Journal of Clinical Oncology · 2010 · 271 citations

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial

Alessandro Rambaldi, Anna Grassi, Arianna Masciulli et al. · The Lancet Oncology · 2015 · 176 citations · Full text

Hematological Malignancy, Transplantation, Marrow Transplantation +11

Neutrophil Activation and Hemostatic Changes in Healthy Donors Receiving Granulocyte Colony-Stimulating Factor

Anna Falanga, Marina Marchetti, Virgilio Evangelista et al. · Blood · 1999 · 157 citations

Lymphomas occurring late after solid-organ transplantation

Gianpietro Dotti, R. Fiocchi, Teresio Motta et al. · Transplantation · 2002 · 138 citations